These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 25573036)

  • 1. Increasing cellular immunogenicity to peptide-based vaccine candidates using a fluorocarbon antigen delivery system.
    Francis JN; Thaburet JF; Bonnet D; Sizer PJ; Brown CB; Georges B
    Vaccine; 2015 Feb; 33(8):1071-6. PubMed ID: 25573036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipopeptide immunization without adjuvant induces potent and long-lasting B, T helper, and cytotoxic T lymphocyte responses against a malaria liver stage antigen in mice and chimpanzees.
    BenMohamed L; Gras-Masse H; Tartar A; Daubersies P; Brahimi K; Bossus M; Thomas A; Druilhe P
    Eur J Immunol; 1997 May; 27(5):1242-53. PubMed ID: 9174617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and preclinical safety evaluation of a new therapeutic HIV-1 vaccine based on 18 T-cell minimal epitope peptides applying a novel cationic adjuvant CAF01.
    Fomsgaard A; Karlsson I; Gram G; Schou C; Tang S; Bang P; Kromann I; Andersen P; Andreasen LV
    Vaccine; 2011 Sep; 29(40):7067-74. PubMed ID: 21767590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of novel helper epitope peptides of Survivin cancer-associated antigen applicable to developing helper/killer-hybrid epitope long peptide cancer vaccine.
    Ohtake J; Ohkuri T; Togashi Y; Kitamura H; Okuno K; Nishimura T
    Immunol Lett; 2014 Sep; 161(1):20-30. PubMed ID: 24794408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IRX-2 increases the T cell-specific immune response to protein/peptide vaccines.
    Naylor PH; Hernandez KE; Nixon AE; Brandwein HJ; Haas GP; Wang CY; Hadden JW
    Vaccine; 2010 Oct; 28(43):7054-62. PubMed ID: 20708999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunization of patients with melanoma peptide vaccines: immunologic assessment using the ELISPOT assay.
    Pass HA; Schwarz SL; Wunderlich JR; Rosenberg SA
    Cancer J Sci Am; 1998; 4(5):316-23. PubMed ID: 9815296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous CD8+ T cell responses to multiple tumor antigen epitopes in a multipeptide melanoma vaccine.
    Valmori D; Dutoit V; Ayyoub M; Rimoldi D; Guillaume P; Liénard D; Lejeune F; Cerottini JC; Romero P; Speiser DE
    Cancer Immun; 2003 Oct; 3():15. PubMed ID: 14580186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intranasal administration is an effective mucosal vaccine delivery route for self-adjuvanting lipid core peptides targeting the group A streptococcal M protein.
    Olive C; Sun HK; Ho MF; Dyer J; Horváth A; Toth I; Good MF
    J Infect Dis; 2006 Aug; 194(3):316-24. PubMed ID: 16826479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rational Design of Antigen Incorporation Into Subunit Vaccine Biomaterials Can Enhance Antigen-Specific Immune Responses.
    Tsoras AN; Wong KM; Paravastu AK; Champion JA
    Front Immunol; 2020; 11():1547. PubMed ID: 32849524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccine Adjuvant Incorporation Strategy Dictates Peptide Amphiphile Micelle Immunostimulatory Capacity.
    Zhang R; Kramer JS; Smith JD; Allen BN; Leeper CN; Li X; Morton LD; Gallazzi F; Ulery BD
    AAPS J; 2018 Jun; 20(4):73. PubMed ID: 29858738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel multi-epitope peptide vaccine against cancer: an in silico approach.
    Nezafat N; Ghasemi Y; Javadi G; Khoshnoud MJ; Omidinia E
    J Theor Biol; 2014 May; 349():121-34. PubMed ID: 24512916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid-core-peptide system for self-adjuvanting synthetic vaccine delivery.
    Skwarczynski M; Toth I
    Methods Mol Biol; 2011; 751():297-308. PubMed ID: 21674338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution of influenza immunity and virosomal-formulated synthetic peptide to cellular immune responses in a phase I subunit malaria vaccine trial.
    Peduzzi E; Westerfeld N; Zurbriggen R; Pluschke G; Daubenberger CA
    Clin Immunol; 2008 May; 127(2):188-97. PubMed ID: 18337175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunization of mice with lipopeptides bypasses the prerequisite for adjuvant. Immune response of BALB/c mice to human immunodeficiency virus envelope glycoprotein.
    Martinon F; Gras-Masse H; Boutillon C; Chirat F; Deprez B; Guillet JG; Gomard E; Tartar A; Levy JP
    J Immunol; 1992 Nov; 149(10):3416-22. PubMed ID: 1385524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptide Amphiphile Micelles for Vaccine Delivery.
    Barrett JC; Tirrell MV
    Methods Mol Biol; 2018; 1798():277-292. PubMed ID: 29868967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Saponins from the Spanish saffron Crocus sativus are efficient adjuvants for protein-based vaccines.
    Castro-Díaz N; Salaun B; Perret R; Sierro S; Romero JF; Fernández JA; Rubio-Moraga A; Romero P
    Vaccine; 2012 Jan; 30(2):388-97. PubMed ID: 22079266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of protective efficacy of the synthetic peptide vaccine containing the T-helper 1 epitope with CpG oligodeoxynucleotide against feline infectious peritonitis virus infection in cats.
    Takano T; Tomizawa K; Morioka H; Doki T; Hohdatsu T
    Antivir Ther; 2014; 19(7):645-50. PubMed ID: 24458025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced protective immune response to PCV2 subunit vaccine by co-administration of recombinant porcine IFN-γ in mice.
    Wang YP; Liu D; Guo LJ; Tang QH; Wei YW; Wu HL; Liu JB; Li SB; Huang LP; Liu CM
    Vaccine; 2013 Jan; 31(5):833-8. PubMed ID: 23219694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel method for enhancement of peptide vaccination utilizing T-cell epitopes from conventional vaccines.
    Yano A; Miwa Y; Kanazawa Y; Ito K; Makino M; Imai S; Hanada N; Nisizawa T
    Vaccine; 2013 Mar; 31(11):1510-5. PubMed ID: 23318151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polygene DNA vaccine induces a high level of protective effect against HIV-vaccinia virus challenge in mice.
    Shinoda K; Xin KQ; Jounai N; Kojima Y; Tamura Y; Okada E; Kawamoto S; Okuda K; Klinman D; Okuda K
    Vaccine; 2004 Sep; 22(27-28):3676-90. PubMed ID: 15315847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.